Oral Oncology
Volume 37, Issue 4 , Pages 341-344, June 2001

Selective deletion of p14(ARF) exon 1β of the INK4a locus in oral squamous cell carcinomas of Indians

  • M Viswanathan

      Affiliations

    • Cancer Biology Division, School of Biological Sciences, Madurai Kamaraj University, Madurai - 625 021, India
  • ,
  • N Tsuchida

      Affiliations

    • Department of Molecular and Cellular Oncology and Microbiology, Tokyo Medical and Dental University, Tokyo 113, Japan
  • ,
  • G Shanmugam

      Affiliations

    • Cancer Biology Division, School of Biological Sciences, Madurai Kamaraj University, Madurai - 625 021, India
    • Corresponding Author InformationCorresponding author. Tel.: +91-452-859126; fax: +91-452-858228

Received 4 September 2000; accepted 27 September 2000.

Abstract 

The tumor suppressor gene — p16 INK4/CDKN2/MTS1 and its alternate splice product p14 (ARF), constitute the INK4a locus. We have examined the integrity of exon 1β of p14(ARF) gene of oral squamous cell carcinomas (n=58) in untreated Indian patients. No mutations were detected in this region by PCR-SSCP analysis of the tumor DNA’s. Further, PCR-based analysis revealed homozygous deletions of exon 1β in 14 of the 58 tumors; these results were confirmed by hybridization of tumor DNAs with exon 1β specific probe. The deletions were limited to the exon 1β while the exons coding p16/INK4 were not affected. Except in two cases these deletions were mutually exclusive to the p53 inactivating mutations. These observations suggest an alternate mechanism of loss of p14(ARF) in the genesis of oral squamous cell carcinomas.

Keywords:  INK4 locus, p14(ARF), Exon 1β, Oral cancers, Selective deletion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(00)00112-3

Oral Oncology
Volume 37, Issue 4 , Pages 341-344, June 2001